NATUROPATHIC DOCTOR IN ONTARIO
The Long-Term Health Risks of Unmanaged PCOS
And What You Can Do To Protect Your Health
Long-Term Health with PCOS
If you’ve ever been told that PCOS is mainly a fertility concern — something to deal with “when you’re ready to get pregnant” — you’ve been given an incomplete picture.
PCOS is a lifelong hormonal and metabolic condition, and its effects extend well beyond the reproductive system. Left unmanaged, it carries meaningful risks across several body systems: cardiovascular, metabolic, endocrine, and gynecological. These risks don’t announce themselves with obvious symptoms in the short term, which is part of why they’re so easy to dismiss — until they’re not.
This post isn’t meant to alarm you. It’s meant to make the case for taking your PCOS seriously at every stage of life, not just when fertility is on the table, and to show you what proactive, ongoing management actually protects you from.
Why PCOS Doesn't "Go Away"
One of the most persistent myths about PCOS is that it resolves after pregnancy, after menopause, or once periods regulate. For many women, cycle irregularity does improve with age — particularly as androgen levels naturally decline in the later reproductive years. But the underlying metabolic drivers of PCOS — primarily insulin resistance and low-grade chronic inflammation — tend to persist and, without intervention, often worsen over time.
This is an important distinction. A woman whose cycles have regulated may feel like her PCOS is “under control,” while her underlying insulin resistance quietly progresses in the background. Regular monitoring and ongoing attention to metabolic health remain relevant throughout the reproductive years and into menopause.
Endometrial Cancer: The Risk That's Most Often Overlooked
One of the most significant and least discussed long-term risks of PCOS is an elevated risk of endometrial cancer — cancer of the lining of the uterus.
In a healthy menstrual cycle, estrogen builds up the endometrial lining during the first half of the cycle, and progesterone — released after ovulation — signals the lining to mature and shed at menstruation. This progesterone exposure is protective: it prevents the endometrium from being continuously exposed to estrogen without opposition.
In PCOS, ovulation is frequently absent or irregular. Without ovulation, there is no progesterone production. The endometrium is exposed to ongoing, unopposed estrogen — a state called estrogen dominance — and without the monthly shedding that progesterone triggers, the lining can thicken over time. This chronic, uninterrupted thickening is a precursor state to endometrial hyperplasia, and over years, can progress to endometrial cancer.
Studies consistently show that women with PCOS have two to three times the risk of endometrial cancer compared to women without the condition. This risk is substantially higher in women who have infrequent periods (fewer than four per year) over extended periods of time.
This is one of the most compelling clinical reasons to work toward more regular ovulation — or, where that isn’t achievable, to discuss with your doctor whether progesterone therapy is appropriate to protect the endometrium. It is also why we take irregular cycles seriously as a medical concern in their own right, regardless of fertility goals.
Iron-Deficiency Anemia: When Heavy or Irregular Bleeding Takes a Toll
PCOS is most commonly associated with infrequent periods — but for a significant subset of women, the pattern is different: cycles are unpredictable, and when periods do arrive, they can be very heavy.
Heavy menstrual bleeding in PCOS occurs partly as a consequence of the endometrial thickening described above. When a prolonged, buildup of the uterine lining finally sheds, the result can be an unusually heavy and prolonged period. Over time, this pattern of blood loss — combined with potentially poor dietary iron intake — can lead to iron-deficiency anemia.
Iron deficiency is one of the most underdiagnosed conditions in women of reproductive age, and its symptoms overlap significantly with PCOS itself: fatigue, brain fog, difficulty concentrating, poor exercise tolerance, cold hands and feet, and low mood. When both are present, each can mask or amplify the other, making it harder to understand what’s driving how you feel.
Routine iron studies — serum ferritin, hemoglobin, and iron saturation — should be part of any comprehensive PCOS workup, and monitoring should continue if heavy or irregular bleeding is part of your pattern. Ferritin in particular can be low even when hemoglobin appears normal, and symptoms of iron deficiency can appear well before anemia is technically present on bloodwork.
Type 2 Diabetes: A Significant and Preventable Risk
Women with PCOS are four to eight times more likely to develop type 2 diabetes than women without the condition. This elevated risk is driven primarily by the insulin resistance that underlies most PCOS presentations — the same mechanism that disrupts ovulation also impairs the body’s ability to regulate blood glucose over time.
Importantly, this progression is not inevitable. Insulin resistance exists on a spectrum, and meaningful intervention early in the course — through dietary changes, regular physical activity, targeted supplementation, and where appropriate, medication — can halt or reverse the trajectory toward type 2 diabetes. The earlier intervention happens, the more leverage there is.
What makes this particularly significant for PCOS is that the progression to type 2 diabetes can be silent for years. Blood glucose may remain in the normal range while insulin is working increasingly hard to keep it there. By the time glucose becomes elevated, insulin-producing capacity has often already been compromised. This is why we test fasting insulin — not just fasting glucose — as a standard part of our PCOS assessment. Catching insulin resistance early, before glucose has been affected, is where the most effective intervention window lies.
Regular monitoring is important even for women who are currently doing well metabolically, as the risk doesn’t disappear with age — in fact, the perimenopausal transition, with its associated shifts in estrogen and insulin sensitivity, can unmask insulin resistance that was previously compensated.
Cardiovascular Disease: A Risk That Begins Early
PCOS is an independent risk factor for cardiovascular disease — a fact that surprises many women (and some clinicians) who associate heart disease primarily with older age or a different patient profile.
The cardiovascular risk in PCOS is driven by a cluster of metabolic factors that frequently co-occur in the condition: insulin resistance, elevated triglycerides, low HDL cholesterol, hypertension, chronic low-grade inflammation, and elevated levels of homocysteine. Together, these constitute what is often called the metabolic syndrome, and women with PCOS have significantly higher rates of it.
Studies have found that women with PCOS have higher rates of subclinical atherosclerosis — early arterial changes that precede overt cardiovascular disease — even in their 30s and 40s. They also have higher rates of hypertension and dyslipidemia that may go undetected if cardiovascular screening isn’t being done proactively.
This doesn’t mean that having PCOS means you will develop heart disease. It means that cardiovascular risk factors deserve attention and active management, starting earlier than standard guidelines might suggest. This includes regular monitoring of blood pressure, a full lipid panel, inflammatory markers, and blood glucose — alongside the dietary and lifestyle interventions that support cardiovascular health alongside hormonal health.
Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic fatty liver disease — the accumulation of fat in the liver in people who drink little or no alcohol — is significantly more common in women with PCOS than in the general population, and is another consequence of the underlying insulin resistance and androgen excess that characterizes the condition.
The liver plays a central role in metabolizing insulin and regulating glucose — when insulin resistance is present, the liver is under greater metabolic stress and fat accumulation in hepatic cells becomes more likely. Elevated androgens also directly contribute to liver fat deposition.
NAFLD often produces no symptoms in its early stages, and is therefore frequently missed unless liver enzymes are tested or imaging is performed. In its more advanced form — non-alcoholic steatohepatitis (NASH) — it involves active liver inflammation and can progress to fibrosis, cirrhosis, and liver failure over decades. Given the long timeframe of progression, early identification and management is far preferable to waiting for symptoms.
Liver enzymes (ALT, AST, GGT) are worth including in routine monitoring for women with PCOS, alongside the metabolic markers above.
Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) — where breathing repeatedly stops and starts during sleep — is significantly more prevalent in women with PCOS than in the general female population, even after controlling for body weight. Elevated androgens are thought to play a role in this relationship, as they influence upper airway muscle tone and central respiratory drive.
Sleep apnea is substantially underdiagnosed in women, in part because it presents differently than the classic picture (loud snoring in an overweight middle-aged man). Women with OSA are more likely to report fatigue, morning headaches, mood disturbance, and difficulty concentrating — symptoms that can easily be attributed to PCOS or other conditions.
This matters for PCOS management because sleep apnea itself worsens insulin resistance, raises cortisol, and disrupts the metabolic health that PCOS treatment is working to restore. If you have PCOS and wake unrefreshed despite adequate hours of sleep, experience morning headaches, or have been told you snore or stop breathing during sleep, it’s worth raising OSA with your doctor.
Mental Health: The Burden That Compounds Everything
While this post focuses on the physical long-term risks, it would be incomplete without acknowledging that women with PCOS have significantly elevated rates of anxiety and depression — rates that are not fully explained by the distress of managing a chronic condition, and appear to have a biological basis in the hormonal and metabolic dysregulation of the condition itself.
Elevated androgens, insulin resistance, and cortisol dysregulation all have direct effects on mood, neurotransmitter function, and nervous system regulation. These are not just “understandable reactions to a difficult diagnosis” — they are physiological consequences of the same imbalances driving the physical symptoms, and they deserve the same clinical attention.
A comprehensive approach to PCOS should include regular screening and honest conversation about mental health — not as an afterthought, but as a core part of monitoring and care.
Monitoring Recommendations for Women With PCOS
Given the range of risks described above, here is a summary of what we recommend monitoring regularly for women with PCOS, regardless of whether fertility is currently a goal:
- Fasting insulin and glucose (and HbA1c) — annually, or more frequently if insulin resistance is already present
- Full lipid panel — including triglycerides, HDL, LDL, and total cholesterol
- Blood pressure — at every clinical encounter
- Iron studies — including serum ferritin, particularly if periods are heavy or irregular
- Liver enzymes (ALT, AST, GGT) — annually
- Pelvic ultrasound and endometrial monitoring — particularly for women with very infrequent periods over extended periods
- Thyroid function — periodically, as thyroid disease co-occurs with PCOS at elevated rates
- Vitamin D — annually; deficiency is common and affects multiple systems
- Mental health screening — at intake and throughout ongoing care
This level of monitoring doesn’t require a specialist — much of it can be done through your GP or naturopathic doctor. What it requires is a clinician who understands that PCOS is a whole-body condition and that regular surveillance is warranted.
The Empowering Side of This Picture
Everything described in this post is worth knowing — and the reason it’s worth knowing is because almost all of these risks are meaningfully modifiable.
Insulin resistance can be improved. Cardiovascular risk factors can be reduced. Endometrial protection can be achieved. Anemia can be corrected. When PCOS is managed proactively — with the right testing, the right interventions, and regular monitoring — the trajectory of these long-term risks changes substantially.
This is why we encourage women with PCOS to stay engaged with their care even in the years when they feel relatively well, cycles seem to be behaving, and fertility isn’t a current concern. The work you do now to address the underlying drivers of your PCOS is an investment in your health at 45, 55, and beyond.
At Sequence Wellness, we support women with PCOS across Ontario with comprehensive, root-cause naturopathic care that takes the long view — addressing what’s driving your symptoms today while keeping an eye on what matters for your health over the long term.
Book a free 10-minute chat to find out if we’re the right fit for you, or explore more of our PCOS resources:
[→ A Naturopathic Approach to PCOS: Treating the Root Cause]
[→ The Four Types of PCOS — And Why Your Treatment Should Match Yours]
[→ PCOS and Insulin Resistance: What Your Blood Sugar Has to Do With Your Hormones]
[→ PCOS and Fertility: How to Support Your Cycle Naturally]
[→ PCOS in Asian Women: Why the Standard Picture Doesn’t Always Fit]
This article is for informational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider for assessment and treatment recommendations specific to your situation. All Sequence Wellness naturopathic doctors are board certified and licensed by the College of Naturopaths of Ontario (CONO).
Dr. Janna Fung, Naturopathic Doctor
Dr. Janna Fung is a licensed naturopathic doctor with a special interest in dermatology and women’s health. She has a passion for evidence based preventative medicine and strives to empower patients with the knowledge to achieve their optimal health. She understands collaborations is the only way to develop realistic sustainable health/wellness results and strives to develop individualized health goals with patients.
